Companies: 48,686 Total Market Cap: 127245292159665.20

CreoSG Co.,Ltd.

KOSDAQ-040350
Computers and Computer Peripheral Equipment and Software
Rank #26357
Market Cap 68.56 M
Volume 258.15
Price 0.36
Change (%) 0.59%
Country or region South Korea South Korea

CreoSG Co.,Ltd.'s latest marketcap:

68.56 M

As of May 12, 2025, CreoSG Co.,Ltd.'s market capitalization has reached $68.56 M. According to our data, CreoSG Co.,Ltd. is the 26357th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 68.56 M
Revenue (ttm) 5.71 M
Net Income (ttm) -8,778,857.63
Shares Out 192.81 M
EPS (ttm) -0.06
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date May 14, 2025
Market Cap Chart
Data Updated: May 12, 2025

CreoSG Co.,Ltd.'s yearly market capitalization.

CreoSG Co.,Ltd. has seen its market value drop from ₩242.31 B to ₩97.95 B since 2020, representing a total decrease of 59.58% and an annual compound decline rate (CAGR) of 18.74%.
Date Market Cap Change (%)
May 12, 2025 ₩97.95 B -8.69%
December 30, 2024 ₩105.58 B 62.94%
December 28, 2023 ₩64.80 B -22.52%
December 29, 2022 ₩83.63 B -41.06%
December 30, 2021 ₩141.90 B -41.44%
December 30, 2020 ₩242.31 B

Company Profile

Company Overview

CreoSG Co., Ltd. is a South Korean company specializing in software solutions for financial institutions, IT services, and innovative drug development. Headquartered in Seoul, the company operates across multiple divisions, delivering technology and healthcare advancements.

Business Divisions

  • Solution Division: Provides bank automation and network control systems (BANCS-K) along with IT outsourcing services such as ERP development, sales system management, and integrated website operations.
  • Product Distribution Division: Distributes IT hardware, including LED/TV monitors, SSDs, computers, laptops, and printers.
  • New Drug and Vaccine Development Division: Focuses on infectious disease vaccines, therapeutic vaccines, and alternative administration methods using VSV vector technology.

Key Offerings

The company's flagship product, BANCS-K, supports financial institutions with automation and network control. Additionally, CreoSG offers:

  • IT system development and management.
  • Hardware distribution for enterprise and consumer markets.
  • Vaccine research targeting HIV/AIDS, COVID-19, Ebola, and other infectious diseases.

Pipeline Highlights

CreoSG's pharmaceutical pipeline includes:

  • SAV001: A Phase 1 HIV/AIDS therapeutic vaccine candidate.
  • Preclinical candidates for COVID-19, hepatitis C, MERS, Zika, and other viruses.

Corporate History

Founded in 1997 as CUROCOM Co., Ltd., the company rebranded to CreoSG Co., Ltd. in March 2024. It continues to expand its footprint in technology and healthcare innovation.

Headquarters: Seoul, South Korea

Frequently Asked Questions

As of May 12, 2025, CreoSG Co.,Ltd. (including the parent company, if applicable) has an estimated market capitalization of $68.56 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

CreoSG Co.,Ltd. global market capitalization ranking is approximately 26357 as of May 12, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region South Korea
Founded 1997
IPO Date n/a
Employees 42
CEO Jung-Gee Cho
Sector
Industry Computers and Computer Peripheral Equipment and Software
Address Illy Building
Seoul
South Korea
People Also Watch
HST
14.77 0.84%
RHP
97.11 0.84%
EPA-COVH
24.50 0.84%
APLE
11.74 0.84%